Digital Biomanufacturing Market Report 2025, Trends And Analysis


The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Digital Biomanufacturing Market Size Growth Potential?
The digital biomanufacturing market size has grown rapidly in recent years. It will grow from $23.97 billion in 2025 to $27.25 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to growth of biologics production, need for process efficiency, adoption of automation in pharma manufacturing, regulatory focus on quality compliance, increasing manufacturing complexity.

The digital biomanufacturing market size is expected to see rapid growth in the next few years. It will grow to $46.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to expansion of cell and gene therapies, adoption of continuous manufacturing, integration of AI in bioprocessing, demand for faster time to market, investment in smart biomanufacturing facilities. Major trends in the forecast period include data driven bioprocess optimization, automation of biomanufacturing operations, digital twin adoption, real time process monitoring, AI enabled quality control.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

Which Major Growth Factors Are Shaping the Digital Biomanufacturing Market?
The growing pharmaceutical industry is expected to drive the growth in digital biomanufacturing going forward. The pharmaceutical industry refers to the sector involved in the research, development, and production of medicines while playing a critical role in healthcare by ensuring the availability of safe and effective treatments. The growing pharmaceutical industry is rising due to increasing global demand for healthcare and medications driven by a larger and aging population, fueling higher production and innovation in drug development to meet expanding medical needs. Digital biomanufacturing helps the pharmaceutical industry by integrating advanced data analytics, automation, and real-time monitoring to optimize drug production, improve quality control, reduce manufacturing costs, and accelerate the development of safe and effective therapies. For instance, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association and lobbying organization, in 2024 North America accounted for 54.8% of estimated world pharmaceutical sales compared with 22.7% for Europe. In 2024 it invested an estimated €55,000 million in R&D in Europe. Therefore, the growing pharmaceutical industry is driving the digital biomanufacturing market.

Which Are the Leading Segments in the Digital Biomanufacturing Market?
The digital biomanufacturing market covered in this report is segmented –

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing

Which Trends Are Most Likely to Influence Digital Biomanufacturing Market Growth in the Next Decade?
Major companies operating in the digital biomanufacturing market are focusing on developing innovative technologies such as single use bioreactors to enhance process efficiency, scalability, and flexibility in biologics production. Single-use bioreactors refer to a type of bioreactor designed for single-use applications in biomanufacturing, eliminating the need for cleaning and sterilization between batches while offering flexibility, reducing contamination risks, and streamlining the production of biologics and vaccines. For instance, in March 2025, European Commission, a Belgium based government agency, launched the Biotech and Biomanufacturing Hub, a dedicated online platform to support biotech and biomanufacturing companies across the EU, especially startups and SMEs, providing one stop access to funding programmes, regulatory guidance, intellectual property support, pilot and testing infrastructure, and networking tools, while also serving as a key part of the Commission’s “Boosting Biotechnology and Biomanufacturing in the EU” strategy aimed at strengthening Europe’s biotech ecosystem, increasing competitiveness, reducing dependence on external supply chains, and streamlining the journey from innovation to commercialisation for biotech-based products.

Which Are the Major Market Players in the Digital Biomanufacturing Industry?
Major companies operating in the digital biomanufacturing market are Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbH

Get the full digital biomanufacturing market report here:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

Which Regions Are Driving the Most Demand in the Digital Biomanufacturing Market?
North America was the largest region in the digital biomanufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more